Literature DB >> 10446167

Identification of the human YVH1 protein-tyrosine phosphatase orthologue reveals a novel zinc binding domain essential for in vivo function.

M Muda1, E R Manning, K Orth, J E Dixon.   

Abstract

A human orthologue of the Saccharomyces cerevisiae YVH1 protein-tyrosine phosphatase is able to rescue the slow growth defect caused by the disruption of the S. cerevisiae YVH1 gene. The human YVH1 gene is located on chromosome 1q21-q22, which falls in a region amplified in human liposarcomas. The evolutionary conserved COOH-terminal noncatalytic domain of human YVH1 is essential for in vivo function. The cysteine-rich COOH-terminal domain is capable of coordinating 2 mol of zinc/mol of protein, defining it as a novel zinc finger domain. Human YVH1 is the first protein-tyrosine phosphatase that contains and is regulated by a zinc finger domain.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10446167     DOI: 10.1074/jbc.274.34.23991

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Redox regulation of the human dual specificity phosphatase YVH1 through disulfide bond formation.

Authors:  Christopher A Bonham; Panayiotis O Vacratsis
Journal:  J Biol Chem       Date:  2009-06-30       Impact factor: 5.157

2.  The dual-specificity protein phosphatase Yvh1p regulates sporulation, growth, and glycogen accumulation independently of catalytic activity in Saccharomyces cerevisiae via the cyclic AMP-dependent protein kinase cascade.

Authors:  A E Beeser; T G Cooper
Journal:  J Bacteriol       Date:  2000-06       Impact factor: 3.490

3.  The Atypical Dual Specificity Phosphatase hYVH1 Associates with Multiple Ribonucleoprotein Particles.

Authors:  Qiudi Geng; Besa Xhabija; Colleen Knuckle; Christopher A Bonham; Panayiotis O Vacratsis
Journal:  J Biol Chem       Date:  2016-11-17       Impact factor: 5.157

4.  A mutant plasma membrane protein is stabilized upon loss of Yvh1, a novel ribosome assembly factor.

Authors:  Yu Liu; Amy Chang
Journal:  Genetics       Date:  2008-12-29       Impact factor: 4.562

5.  Efficacious immune therapy in chronic myelogenous leukemia (CML) recognizes antigens that are expressed on CML progenitor cells.

Authors:  Melinda A Biernacki; Ovidiu Marina; Wandi Zhang; Fenglong Liu; Ingmar Bruns; Ann Cai; Donna Neuberg; Christine M Canning; Edwin P Alyea; Robert J Soiffer; Vladimir Brusic; Jerome Ritz; Catherine J Wu
Journal:  Cancer Res       Date:  2010-01-26       Impact factor: 12.701

6.  Characterization of a human cell line stably over-expressing the candidate oncogene, dual specificity phosphatase 12.

Authors:  Erica L Cain; Sterling E Braun; Alexander Beeser
Journal:  PLoS One       Date:  2011-04-20       Impact factor: 3.240

7.  Mapping and characterization of the amplicon near APOA2 in 1q23 in human sarcomas by FISH and array CGH.

Authors:  Stine H Kresse; Jeanne-Marie Berner; Leonardo A Meza-Zepeda; Simon G Gregory; Wen-Lin Kuo; Joe W Gray; Anne Forus; Ola Myklebost
Journal:  Mol Cancer       Date:  2005-11-07       Impact factor: 27.401

8.  Ribosome stalk assembly requires the dual-specificity phosphatase Yvh1 for the exchange of Mrt4 with P0.

Authors:  Kai-Yin Lo; Zhihua Li; Feng Wang; Edward M Marcotte; Arlen W Johnson
Journal:  J Cell Biol       Date:  2009-09-21       Impact factor: 10.539

9.  POLAR MAPPER: a computational tool for integrated visualization of protein interaction networks and mRNA expression data.

Authors:  Joana P Gonçalves; Mário Grãos; André X C N Valente
Journal:  J R Soc Interface       Date:  2008-11-28       Impact factor: 4.118

10.  Yvh1 is required for a late maturation step in the 60S biogenesis pathway.

Authors:  Stefan Kemmler; Laura Occhipinti; Maria Veisu; Vikram Govind Panse
Journal:  J Cell Biol       Date:  2009-09-21       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.